A large-scale trial testing the intensity of cytoreductive therapy to prevent cardiovascular events
In the first randomized clinical trial assessing the proper target hematocrit level, or percentage of red blood cells that should be maintained in patients with polycythemia vera (PV), researchers have concluded that the ...
Dec 9, 2012
0
0